With Closer Eye On Indian Units, U.S. FDA Names Altaf Lal As New Country Director
This article was originally published in PharmAsia News
Executive Summary
Four years after it established its first India base, U.S. FDA has effected a leadership change. The new chief is expected to play a double role as both guide and vigilant examiner.